Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

News2007May › Drug Protests: Patient groups campaign for their sponsors › May 2007

Drug Protests: Patient groups campaign for their sponsors

NICE (National Institute of Health and Clinical Excellence), the much-maligned body that determines which drugs should be available on the UK's National Health Service, is finally fighting back

NICE (National Institute of Health and Clinical Excellence), the much-maligned body that determines which drugs should be available on the UK's National Health Service, is finally fighting back.

Of late, it's been the whipping boy of drug companies and irate patients who blame it for blocking 'life-saving' drugs. Drug companies have threatened to withdraw investment in the UK unless NICE starts approving their drugs. And now several of them are threatening to sue NICE over its recent decisions.
So NICE has finally decided to get a little nasty. It's been pointing out that the manufacturers themselves fund many of the patient groups that are campaigning for the drugs' admittance to the NHS.

Sir Michael Rawlins, NICE's chairman, describes the relationship as 'distasteful'.

The Alzheimer's Society has led a patient revolt against NICE's ruling to bar dementia drugs Aricept, Reminyl and Exelon from the NHS. In the last year, the society received funding of lb31,000 from Pfizer, which makes Aricept, lb13,000 from Shire Pharmaceuticals, which makes Reminyl, and lb14,000 from Novartis, which makes Exelon.

Similarly, patient group Cancerbackup, one of the chief campaigners against NICE's ruling on breast cancer 'wonder' drug Herceptin, receives lb29,000 funding from Roche, Herceptin's manufacturer.

(Source: Sunday Times, 3 December, 2006).

E-news broadcast 7 December 2006 No.316 [Subscribe]


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved